380 related articles for article (PubMed ID: 26223645)
1. Antagonistic Relationship between Human Cytomegalovirus pUL27 and pUL97 Activities during Infection.
Bigley TM; Reitsma JM; Terhune SS
J Virol; 2015 Oct; 89(20):10230-46. PubMed ID: 26223645
[TBL] [Abstract][Full Text] [Related]
2. Antiviral inhibition targeting the HCMV kinase pUL97 requires pUL27-dependent degradation of Tip60 acetyltransferase and cell-cycle arrest.
Reitsma JM; Savaryn JP; Faust K; Sato H; Halligan BD; Terhune SS
Cell Host Microbe; 2011 Feb; 9(2):103-14. PubMed ID: 21320693
[TBL] [Abstract][Full Text] [Related]
3. Clinical development of letermovir and maribavir: Overview of human cytomegalovirus drug resistance.
Piret J; Boivin G
Antiviral Res; 2019 Mar; 163():91-105. PubMed ID: 30690043
[TBL] [Abstract][Full Text] [Related]
4. Conserved domains and structure prediction of human cytomegalovirus UL27 protein.
Hantz S; Couvreux A; Champier G; Trapes L; Cotin S; Denis F; Bouaziz S; Alain S
Antivir Ther; 2009; 14(5):663-72. PubMed ID: 19704169
[TBL] [Abstract][Full Text] [Related]
5. Resistance to maribavir is associated with the exclusion of pUL27 from nucleoli during human cytomegalovirus infection.
Hakki M; Drummond C; Houser B; Marousek G; Chou S
Antiviral Res; 2011 Nov; 92(2):313-8. PubMed ID: 21906628
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of cellular STAT3 synergizes with the cytomegalovirus kinase inhibitor maribavir to disrupt infection.
Reitsma JM; Terhune SS
Antiviral Res; 2013 Nov; 100(2):321-7. PubMed ID: 24070820
[TBL] [Abstract][Full Text] [Related]
7. Differential properties of cytomegalovirus pUL97 kinase isoforms affect viral replication and maribavir susceptibility.
Webel R; Hakki M; Prichard MN; Rawlinson WD; Marschall M; Chou S
J Virol; 2014 May; 88(9):4776-85. PubMed ID: 24522923
[TBL] [Abstract][Full Text] [Related]
8. Proteomic Interaction Patterns between Human Cyclins, the Cyclin-Dependent Kinase Ortholog pUL97 and Additional Cytomegalovirus Proteins.
Steingruber M; Kraut A; Socher E; Sticht H; Reichel A; Stamminger T; Amin B; Couté Y; Hutterer C; Marschall M
Viruses; 2016 Aug; 8(8):. PubMed ID: 27548200
[TBL] [Abstract][Full Text] [Related]
9. Regulatory roles of protein kinases in cytomegalovirus replication.
Marschall M; Feichtinger S; Milbradt J
Adv Virus Res; 2011; 80():69-101. PubMed ID: 21762822
[TBL] [Abstract][Full Text] [Related]
10. Cyclin-Dependent Kinases (CDKs) and the Human Cytomegalovirus-Encoded CDK Ortholog pUL97 Represent Highly Attractive Targets for Synergistic Drug Combinations.
Wild M; Hahn F; Brückner N; Schütz M; Wangen C; Wagner S; Sommerer M; Strobl S; Marschall M
Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269635
[TBL] [Abstract][Full Text] [Related]
11. Cytomegalovirus cyclin-dependent kinase ortholog vCDK/pUL97 undergoes regulatory interaction with human cyclin H and CDK7 to codetermine viral replication efficiency.
Schütz M; Wangen C; Sommerer M; Kögler M; Eickhoff J; Degenhart C; Klebl B; Naing Z; Egilmezer E; Hamilton ST; Rawlinson WD; Sticht H; Marschall M
Virus Res; 2023 Oct; 335():199200. PubMed ID: 37591314
[TBL] [Abstract][Full Text] [Related]
12. Functional Relevance of the Interaction between Human Cyclins and the Cytomegalovirus-Encoded CDK-Like Protein Kinase pUL97.
Schütz M; Steingruber M; Socher E; Müller R; Wagner S; Kögel M; Sticht H; Marschall M
Viruses; 2021 Jun; 13(7):. PubMed ID: 34198986
[TBL] [Abstract][Full Text] [Related]
13. The chemical class of quinazoline compounds provides a core structure for the design of anticytomegaloviral kinase inhibitors.
Hutterer C; Hamilton S; Steingruber M; Zeitträger I; Bahsi H; Thuma N; Naing Z; Örfi Z; Örfi L; Socher E; Sticht H; Rawlinson W; Chou S; Haupt VJ; Marschall M
Antiviral Res; 2016 Oct; 134():130-143. PubMed ID: 27515131
[TBL] [Abstract][Full Text] [Related]
14. The Interactive Complex between Cytomegalovirus Kinase vCDK/pUL97 and Host Factors CDK7-Cyclin H Determines Individual Patterns of Transcription in Infected Cells.
Schütz M; Cordsmeier A; Wangen C; Horn AHC; Wyler E; Ensser A; Sticht H; Marschall M
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139252
[TBL] [Abstract][Full Text] [Related]
15. Impact of RNA polymerase I inhibitor CX-5461 on viral kinase-dependent and -independent cytomegalovirus replication.
Westdorp KN; Terhune SS
Antiviral Res; 2018 May; 153():33-38. PubMed ID: 29458130
[TBL] [Abstract][Full Text] [Related]
16. Diverse cytomegalovirus UL27 mutations adapt to loss of viral UL97 kinase activity under maribavir.
Chou S
Antimicrob Agents Chemother; 2009 Jan; 53(1):81-5. PubMed ID: 18981262
[TBL] [Abstract][Full Text] [Related]
17. Abemaciclib restricts HCMV replication by suppressing pUL97-mediated phosphorylation of SAMHD1.
Syrigos GV; Feige M; Dirlam A; Businger R; Gruska I; Wiebusch L; Hamprecht K; Schindler M
Antiviral Res; 2023 Sep; 217():105689. PubMed ID: 37516154
[TBL] [Abstract][Full Text] [Related]
18. Human cytomegalovirus pUL97 regulates the viral major immediate early promoter by phosphorylation-mediated disruption of histone deacetylase 1 binding.
Bigley TM; Reitsma JM; Mirza SP; Terhune SS
J Virol; 2013 Jul; 87(13):7393-408. PubMed ID: 23616659
[TBL] [Abstract][Full Text] [Related]
19. Highly Conserved Interaction Profiles between Clinically Relevant Mutants of the Cytomegalovirus CDK-like Kinase pUL97 and Human Cyclins: Functional Significance of Cyclin H.
Schütz M; Müller R; Socher E; Wangen C; Full F; Wyler E; Wong D; Scherer M; Stamminger T; Chou S; Rawlinson WD; Hamilton ST; Sticht H; Marschall M
Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233116
[TBL] [Abstract][Full Text] [Related]
20. Novel mode of phosphorylation-triggered reorganization of the nuclear lamina during nuclear egress of human cytomegalovirus.
Milbradt J; Webel R; Auerochs S; Sticht H; Marschall M
J Biol Chem; 2010 Apr; 285(18):13979-89. PubMed ID: 20202933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
